quinoxalines has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, AL; Moraes, MO; Oliveira, GJ; Pinheiro, CA; Ribeiro, RA; Souza, MH; Torres, JN; Vale, ML | 1 |
| Alwani, DW; Masters, BR; Noble, AC; Popp, FD; Schuyler, P | 1 |
2 other study(ies) available for quinoxalines and Carcinoma 256, Walker
| Article | Year |
|---|---|
Participation of the NO/cGMP/K+ATP pathway in the antinociception induced by Walker tumor bearing in rats.
Topics: Analgesics; Animals; Arginine; Carcinoma 256, Walker; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; KATP Channels; Male; Nitric Oxide; Nociception; Oxadiazoles; Pain Measurement; Pain Threshold; Quinoxalines; Rats; Rats, Wistar; Signal Transduction | 2012 |
Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chemistry, Organic; Female; Leiomyosarcoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Neoplasms, Experimental; Organic Chemistry Phenomena; Quinolines; Quinoxalines; Sarcoma 180; Sarcoma, Experimental; Sarcoma, Yoshida; Uterine Neoplasms | 1966 |